Comparison of Outcomes Between HER2+ Stage 3B/3C and Stage 4 Bone-Only Metastatic Breast Cancer (BC) Patients: A Cohort Study with a Focus on No Evidence of Disease (NED) Status

• Aim: Compare overall survival (OS) and progression-free survival (PFS) between Stage 3B/3C and Stage 4 HER2+ BOMBC patients, focusing on achieving No Evidence of Disease (NED).

• Design: Multicenter, retrospective cohort study.

• Highlights:

  • Investigates the prognostic value of NED.

  • Explores predictors of durable remission (systemic therapy, surgery, bone-targeted agents).

• Status: Recruiting centers – ongoing data collection.

• Please contact us at berkgoktepe@gmail.com

protokol HER2+ comparison ENG.docx

Download DOCX • 35KB